Actavis Tells Judge Purdue's Oxy Patents Rely On Minor Tweak
A chemical tweak should not allow Purdue Pharma LP to monopolize sales of the popular pain killer oxycodone for years, Actavis Elizabeth LLC argued Friday in a trial over whether Purdue's...To view the full article, register now.
Already a subscriber? Click here to view full article